SpreeHealth
Drug price

Citalopram: here's the fair price

This is what US pharmacies pay, on average, for citalopram. Use it to spot a fair cash price, and feel good about asking for one.

Lowest generic tablet or capsule

Citalopram Hbr 10 Mg Tablet

$0.86
pharmacy cost for 30

A fair cash price is usually this cost plus a dispensing fee. If your quote is many times higher, ask about a generic, another pharmacy, or a cash discount.

Your best move

Ask for generic Citalopram Hbr 10 Mg Tablet. Pharmacies pay about $0.86 for 30. Ask your pharmacy for its cash price and compare it with your copay. A fair cash price is close to this cost plus a dispensing fee.

Source: CMS NADAC as of 2026-11-04. Ask your prescriber or pharmacist whether a generic is right for you.

Source: CMS NADAC weekly file as of 2026-11-04. Median across NDCs with the same description. Public domain.

Pharmacies near you

Your ZIP and location stay in your browser. We never store them.

Every strength and form

ProductPharmacy cost30 countEffective
CITALOPRAM HBR 10 MG TABLETGeneric$0.03
per tablet or capsule
$0.8610/21/2026
CITALOPRAM HBR 20 MG TABLETGeneric$0.03
per tablet or capsule
$0.9110/21/2026
CITALOPRAM HBR 40 MG TABLETGeneric$0.04
per tablet or capsule
$1.2510/21/2026
CITALOPRAM HBR 10 MG/5 ML SOLNGeneric$0.19
per mL
n/a10/21/2026
CITALOPRAM HBR 30 MG CAPSULEGeneric$4.74
per tablet or capsule
$142.0610/21/2026

Source: CMS NADAC, as of 2026-11-04. National average acquisition cost, not a retail quote.

Label basics

What it is used for (FDA label)

1 INDICATIONS AND USAGE Citalopram tablets are indicated for the treatment of major depressive disorder (MDD) in adults [see Clinical Studies ( 14 )] . Citalopram is a selective serotonin reuptake inhibitor (SSRI) indicated for the treatment of major depressive disorder (MDD) in adults ( 1 ) .

Boxed warning (from the label): WARNING: SUICIDAL THOUGHTS AND BEHAVIORS Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short- term studies. Closely monitor all antidepressant-treated patients for clinical worsening, and for emergence of suicidal thoughts and behaviors [see Warnings and Precautions ( 5.1 )] . Citalopram tablets are not approved for use in pediatric patients [see Use in Specific Populations ( 8.4 )] . WARNING: SUICIDAL THOUGHTS AND BEHAVIORS See...

Common side effects (FDA label)

6 ADVERSE REACTIONS The following adverse reactions are discussed in greater detail in other sections of the labeling: • Hypersensitivity reactions [see Contraindications ( 4 )] • Suicidal thoughts and behaviors in adolescents and young adults [see Warnings and Precautions ( 5.1 )] • QT-prolongation and torsade de pointes [see Warnings and Precautions ( 5.2 )] • Serotonin syndrome [see Warnings and Precautions ( 5.3 )] • Increased risk of bleeding [see Warnings and Precautions ( 5.4 )] • Activation of mania or hypomania [see Warnings and Precautions ( 5.5 )] • Discontinuation syndrome [see...

Drug interactions (from the label)

7 DRUG INTERACTIONS Table 5 presents clinically important drug interactions with citalopram. Table 5: Clinically Important Drug Interactions with Citalopram Monoamine Oxidase Inhibitors (MAOIs) Clinical Impact Concomitant use of SSRIs, including citalopram, and MAOIs increases the risk of serotonin syndrome. Intervention Citalopram is contraindicated in patients taking MAOIs, including MAOIs such as linezolid or intravenous methylene blue [see Dosage and Administration ( 2.5 ), Contraindications ( 4 ), Warnings and Precautions ( 5.3 )] . Pimozide Clinical Impact: Concomitant use of citalopram with pimozide increases plasma concentrations of pimozide, a drug with a narrow therapeutic index,...

Warnings (from the label)

5 WARNINGS AND PRECAUTIONS • QT-Prolongation and Torsade de Pointes: Dose-dependent QTc prolongation, Torsade de pointes, ventricular tachycardia, and sudden death have occurred. Avoid use of citalopram tablets in patients with congenital long QT syndrome, bradycardia, hypokalemia or hypomagnesemia, recent acute myocardial infarction, or uncompensated heart failure and patients taking other drugs that prolong the QTc interval. Monitor electrolytes in patients at high risk for hypokalemia or hypomagnesemia. Discontinue citalopram tablets in patients with persistent QTc measurements > 500 ms ( 5.2 , 7 ). • Serotonin Syndrome: Increased risk when co-administered with other serotonergic agents,...

Source: FDA drug label via openFDA, label effective 2026-02-04. Full label on DailyMed. Excerpts are verbatim and truncated. Read the full label and ask your pharmacist.